Form D Worth Mentioning: Praxis Precision Medicines $7.74 million Fundraising. Kiran Reddy Published Nov 7 Form D

Pharmaceuticals Praxis Precision Medicines, Inc. - Kiran Reddy

Praxis Precision Medicines Financing

Praxis Precision Medicines, Inc., Corporation just released form D announcing $7.74 million equity financing. This is a new filing. Praxis Precision Medicines was able to finance itself with $3.08 million so far. That is 39.81% of the financing offer. The total fundraising amount was $7.74 million. The private financing document was filed on 2016-11-07. The reason for the financing was: unspecified. The fundraising still has about $4.66 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Praxis Precision Medicines is based in Massachusetts. The company’s business is Pharmaceuticals. The D form was submitted by Kiran Reddy President. The company was incorporated in 2015. The filler’s address is: 101 Main Street, #1210, Cambridge, Ma, Massachusetts, 02142. Kiran Reddy is the related person in the form and it has address: C/O Praxis Precision Medicines, Inc., 101 Main Street, #1210, Cambridge, Ma, Massachusetts, 02142. Link to Praxis Precision Medicines Filing: 000168954816000001.

Analysis of Praxis Precision Medicines Offering

On average, startups in the Pharmaceuticals sector, sell 60.90% of the total offering size. Praxis Precision Medicines sold 39.81% of the offering. The financing is still open. The average offering amount for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 454.29% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this offering is set at $0. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Praxis Precision Medicines Also

The Form D signed by Kiran Reddy might help Praxis Precision Medicines, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment